Cargando…

Epigallocatechin‐3‐gallate sensitises multidrug‐resistant oral carcinoma xenografts to vincristine sulfate

Oral squamous cell carcinoma (OSCC) is a very aggressive malignancy, and 50% of patients who receive curative treatment die from the disease or related complications within 5 years. Epigallocatechin‐3‐gallate (EGCG) is the most abundant bioactive ingredient of tea polyphenols in green tea and has an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Li, Guo, Xianwen, Hu, Ye, Li, Li, Liang, Gang, Zhang, Guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327922/ https://www.ncbi.nlm.nih.gov/pubmed/32475087 http://dx.doi.org/10.1002/2211-5463.12905

Ejemplares similares

Antitumor Effect of Epigallocatechin Gallate and Vincristine in Mice with L5178Y Lymphoma
por: Almaguer, Georgina, et al.
Publicado: (2023)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii
por: Betts, Jonathan W, et al.
Publicado: (2014)

Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts
por: Wei, Ran, et al.
Publicado: (2019)

Epigallocatechin-3-gallate Modulates MicroRNA Expression Profiles in Human Nasopharyngeal Carcinoma CNE2 Cells
por: Li, Bin-Bin, et al.
Publicado: (2017)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Neuroprotective Activity of (−)-Epigallocatechin Gallate against Lipopolysaccharide-Mediated Cytotoxicity
por: Liu, Jin-Biao, et al.
Publicado: (2016)

Effect of Y(6), an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells
por: Wen, Yan, et al.
Publicado: (2017)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

In Vitro Evaluation of the Antiviral Activity of the Synthetic Epigallocatechin Gallate Analog-Epigallocatechin Gallate (EGCG) Palmitate against Porcine Reproductive and Respiratory Syndrome Virus
por: Zhao, Chunjian, et al.
Publicado: (2014)

Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs
por: Wang, Chunguang, et al.
Publicado: (2023)

Marqibo(®) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
por: Silverman, Jeffrey A., et al.
Publicado: (2012)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats
por: Wang, Yu, et al.
Publicado: (2020)

Dietary Copper Reduces the Hepatotoxicity of (−)-Epigallocatechin-3-Gallate in Mice
por: Kaleri, Najeeb Ahmed, et al.
Publicado: (2017)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
por: Tang, L., et al.
Publicado: (2017)

Epigallocatechin-3-Gallate Reduces Fat Accumulation in Caenorhabditis elegans
por: Liu, Jinning, et al.
Publicado: (2018)

Bioaccessibility and Bioavailability of (-)-Epigallocatechin Gallate in the Bread Matrix with Glycemic Reduction
por: Li, Lanqi, et al.
Publicado: (2022)

A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine.
por: Evans, B. D., et al.
Publicado: (1982)

The therapeutic potential of epigallocatechin-3-gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study
por: Yoshimura, Hitoshi, et al.
Publicado: (2019)

Epigallocatechin gallate (EGCG) combined with zinc sulfate inhibits Peste des petits ruminants virus entry and replication
por: Saadh, Mohamed
Publicado: (2021)

In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
por: Wang, Wang, et al.
Publicado: (2019)

Y(6), an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
por: Zhao, Rui-Qiang, et al.
Publicado: (2019)

Conventional-Vincristine Sulfate vs. Modified Protocol of Vincristine Sulfate and L-Asparaginase in Canine Transmissible Venereal Tumor
por: Setthawongsin, Chanokchon, et al.
Publicado: (2019)

Epigallocatechin-3-gallate-induced vascular normalization in A549-cell xenograft-bearing nude mice: therapeutic efficacy in combination with chemotherapy
por: Deng, Pengbo, et al.
Publicado: (2019)

Effects of artificial honey and epigallocatechin-3-gallate on streptococcus pyogenes
por: Jiang, Xiaoge, et al.
Publicado: (2022)

Effects of Epigallocatechin Gallate on the Stability of Epicatechin in a Photolytic Process
por: Huang, Shiuh-Tsuen, et al.
Publicado: (2019)

Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1
por: Li, Xiaoguang, et al.
Publicado: (2017)

Food Inhibits the Oral Bioavailability of the Major Green Tea Antioxidant Epigallocatechin Gallate in Humans
por: Naumovski, Nenad, et al.
Publicado: (2015)

Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant Vibrio cholerae
por: Siriphap, Achiraya, et al.
Publicado: (2022)

Advanced Nanovehicles-Enabled Delivery Systems of Epigallocatechin Gallate for Cancer Therapy
por: Li, Kai, et al.
Publicado: (2020)

Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion
por: Chan, Chi-Ming, et al.
Publicado: (2010)

Broad inhibition of plasmodium falciparum cytoadherence by (+)-epigallocatechin gallate
por: Patil, Pradeep R, et al.
Publicado: (2011)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bo9kteq69mfavj8g1m1nk78t5a